Retatrutide is an investigational triple receptor agonist targeting GLP-1, GIP, and glucagon receptors not yet approved by the MHRA or EMA as of April 2025
Skin pathway and pigmentation In skin cells, glutathione can influence melanin production, which links to skin lightening, skin tone lightening, and skin brightening
This medication has been making headlines recently for its impressive results in clinical trials, and for good reason
Scientific References Topamax 25 mg Tablets Summary of Product Characteristics
Gradual dose escalation over 4-8 weeks allows assessment of individual response and tolerance
The transient nature of blood pressure changes, combined with the on-demand dosing strategy, mitigates concerns about sustained cardiovascular effects during long-term use